Stay updated on Idasanutlin Combo Therapy in AML Clinical Trial
Sign up to get notified when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.

Latest updates to the Idasanutlin Combo Therapy in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, along with a banner about government funding; these changes affect only site metadata and banners, not the study details.SummaryDifference0.3%

- Check21 days agoChange DetectedAn administrative notice about government funding and NIH operations status was added, and the revision label changed to v3.4.1 (v3.4.0 removed), which appears cosmetic and does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedShow glossary now appears on the page; QC-related labels have been reformatted (Last Update Submitted that Met QC Criteria) and No FEAR Act Data capitalization adjusted. Revision updated from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded detailed Locations sections for numerous US states (California, Colorado, Illinois, Iowa, Kansas, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, Texas) and international sites (Victoria, Emilia-Romagna, Lombardy) and updated the revision to v3.3.3. Removed the previous location lists (v3.3.2 reference) and updated the revision accordingly.SummaryDifference1%

- Check85 days agoChange DetectedRevision: v3.3.2 has been added, replacing the prior v3.3.1.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Idasanutlin Combo Therapy in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.